AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMRICOR MEDICAL SYSTEMS-CDI

2.010

-0.040-1.95%

Volume:415.17K

Turnover:829.32K

Market Cap:720.67M

PE:-11.76

High:2.030

Open:2.030

Low:1.955

Close:2.050

52wk High:2.250

52wk Low:1.275

Shares:358.54M

Float Shares:275.05M

Volume Ratio:1.02

T/O Rate:0.15%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.171

EPS(LYR):-0.114

ROE:-143.12%

ROA:-26.53%

PB:17.77

PE(LYR):-17.57

Loading ...

Overview Company News Filings

Imricor Medical Systems, - Submission Includes Vision-Mr Ablation Catheter 2, RF-5000 Generator, RF-5000 Tubing Set

THOMSON REUTERS

Imricor Medical Systems Granted Waiver From Certain ASX Listing Rules After Becoming US Public Reporting Company

MT Newswires Live

Imricor Medical Systems Inc - Granted ASX Waiver From Listing Rules Effective 26 May 2026

THOMSON REUTERS

Imricor Medical Systems Inc-Update - Notification Regarding Unquoted Securities - Imr

THOMSON REUTERS

BUZZ-Australia's Imricor Medical Systems slips on discounted placement

Imricor Medical Systems Secures AU$60 Million in Institutional Placement

MT Newswires Live

BRIEF-Imricor Medical Systems To Raise A$60 Mln At A$1.85 Per Share

Imricor Medical Systems - to Raise a$60.0 Mln at an Offer Price of a$1.85 per Share

THOMSON REUTERS

BRIEF-Imricor Medical Systems Seeks Trading Halt Pending Announcement On Proposed Capital Raising

Imricor Medical Systems Inc - Trading Halt Requested Pending Announcement on Proposed Capital Raising

THOMSON REUTERS

Imricor Medical Systems Expects First Sales for Mapping System in Q2

MT Newswires Live

ASX Penny Stocks Worth Watching In April 2026

Simply Wall St.

BRIEF-Imricor Medical Systems Submits Northstar For U.S. Pediatric Expansion

Imricor Medical Systems Submits Mapping System to US FDA for Pediatric Label Expansion

MT Newswires Live

Imricor Medical Systems Inc - Imricor Submits Northstar for U.S. Pediatric Expansion

THOMSON REUTERS

Imricor Medical Systems Inc - US FDA Clearance Is Expected in Current Quarter

THOMSON REUTERS

BRIEF-Imricor Medical Systems Net Loss For Year $25.3 Million

Imricor Medical Systems Posts Narrower 2025 Loss, Lower Revenue

MT Newswires Live

Imricor Medical Systems Inc - Net Loss for Year $25.3 Mln

THOMSON REUTERS

Imricor Medical Systems Secures Third Site for Heart Procedure Trial

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/IMR.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","market":"AU","secType":"STK","nameCN":"IMRICOR MEDICAL SYSTEMS-CDI","latestPrice":2.01,"timestamp":1787292720000,"preClose":2.05,"halted":0,"volume":415168,"delay":0,"changeRate":-0.019512195121951237,"nameEN":"IMRICOR MEDICAL SYSTEMS-CDI","floatShares":275046474,"shares":358542497,"eps":-0.17091670154876515,"marketStatus":"Market Closed","change":-0.04,"latestTime":"08-21 16:12:00 AEST","open":2.03,"high":2.03,"low":1.955,"amount":829322,"amplitude":0.036585,"askPrice":2.05,"askSize":10414,"bidPrice":1.96,"bidSize":41400,"shortable":3,"etf":0,"ttmEps":-0.17091670154876515,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":2.05,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":1.0159823998285065,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IMR.AU","preClose":2.05,"auctionPrice":1.995,"auctionVolume":13919,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292600775}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","floatShares":275046474,"roa":"-26.53%","roe":"-143.12%","lyrEps":-0.114417,"volumeRatio":1.0159823998285065,"shares":358542497,"dividePrice":0,"high":2.03,"amplitude":0.036585,"preClose":2.05,"low":1.955,"week52Low":1.275,"pbRate":"17.77","psRate":"4301.44","week52High":2.25,"institutionHeld":0,"latestPrice":2.01,"committee":0.598024,"eps":-0.17091670154876515,"divideRate":0,"volume":415168,"delay":0,"ttmEps":-0.17091670154876515,"open":2.03,"prevYearClose":1.53,"prevWeekClose":2.04,"prevMonthClose":1.86,"prevQuarterClose":1.845,"fiveDayClose":2.04,"twentyDayClose":1.92,"sixtyDayClose":1.74,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMR.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-10","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786320000000,"name":null,"time":"","dateTimestamp":1786284000000,"actualEps":null},{"date":"2026-02-24","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771887600000,"name":null,"time":"","dateTimestamp":1771851600000,"actualEps":null},{"date":"2025-08-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756166400000,"name":null,"time":"","dateTimestamp":1756130400000,"actualEps":null},{"date":"2025-02-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-28","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724803200000,"name":null,"time":"","dateTimestamp":1724767200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMR.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642471023","title":"Imricor Medical Systems, - Submission Includes Vision-Mr Ablation Catheter 2, RF-5000 Generator, RF-5000 Tubing Set","url":"https://stock-news.laohu8.com/highlight/detail?id=2642471023","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642471023?lang=en_us&edition=fundamental","pubTime":"2026-06-11 06:55","pubTimestamp":1781132143,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nTUEQP6L8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","BK7007","IMR.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638552965","title":"Imricor Medical Systems Granted Waiver From Certain ASX Listing Rules After Becoming US Public Reporting Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2638552965","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638552965?lang=en_us&edition=fundamental","pubTime":"2026-05-27 07:52","pubTimestamp":1779839554,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  was granted a waiver from certain ASX listing rules, effective Tuesday, in order to align its ASX periodic reporting with the reporting requirements in its home jurisdiction in the US, according to a Wednesday Australian bourse filing.The company said its registration statement on Form 10 became effective on May 17, making it a US public reporting company, subject to the periodic reporting requirements, including requirements to file annual reports on Form 10-K, quarterly reports on Form 10-Q, and periodic reports on Form 8-K with the US Securities and Exchange Commission .Imricor will not be required to lodge an Appendix 4D, an Appendix 4E, and an Appendix 4C.The waiver will cease to apply if Imricor ceases to be subject to an obligation to file Forms 10-K and Forms 10-Q with the US SEC.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SEC.AU","BK7007","BK7503","BK7508","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638526947","title":"Imricor Medical Systems Inc - Granted ASX Waiver From Listing Rules Effective 26 May 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2638526947","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638526947?lang=en_us&edition=fundamental","pubTime":"2026-05-27 07:13","pubTimestamp":1779837193,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUE6MMLK1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMR.AU","BK7508","BK7503","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637871467","title":"Imricor Medical Systems Inc-Update - Notification Regarding Unquoted Securities - Imr","url":"https://stock-news.laohu8.com/highlight/detail?id=2637871467","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637871467?lang=en_us&edition=fundamental","pubTime":"2026-05-21 07:33","pubTimestamp":1779320022,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUEBHFCQD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","BK7007","BK7508","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632598005","title":"BUZZ-Australia's Imricor Medical Systems slips on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2632598005","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632598005?lang=en_us&edition=fundamental","pubTime":"2026-05-04 13:06","pubTimestamp":1777871211,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Imricor Medical Systems slips on discounted placement** Shares of Imricor Medical Systems IMR.AX fall as much as 6.3% to A$1.85, their lowest level since April 14** On track to mark worst session since April 22** Medical device developer receives firm commitments to raise A$60 million  via placement** Offer price of A$1.85 represents a 6.3% discount to its last close** Proceeds will be used to accelerate Imricor’s growth strategy, including launching NorthStar in the U.S., and others, co says** Up 22.6% YTD, including session's moves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL6N41H04I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7503","IMR.AU","BK7007","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632598487","title":"Imricor Medical Systems Secures AU$60 Million in Institutional Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2632598487","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632598487?lang=en_us&edition=fundamental","pubTime":"2026-05-04 09:24","pubTimestamp":1777857871,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  has secured firm commitments from new and existing institutional and sophisticated investors to raise AU$60 million through the issue of 32.4 million Chess depositary interests  at AU$1.85 per CDI, reflecting a 7.7% discount to its 10-day volume-weighted average price, according to a Monday Australian bourse filing.The new CDIs will be issued in a single tranche under the company's existing placement capacity and will rank equally with existing CDIs, per the filing.Settlement is expected on Thursday, with the new CDIs scheduled for issuance and set to begin trading on the Australian Securities Exchange on Friday, the filing said.The funds will be used to accelerate the company's growth strategy, including launching NorthStar in the US, advancing regulatory approvals for its full electrophysiology platform, completing key clinical programs, progressing pulsed field ablation development, and supporting expansion in the Middle East and other target markets, the fi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","BK7508","IMR.AU","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632810299","title":"BRIEF-Imricor Medical Systems To Raise A$60 Mln At A$1.85 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2632810299","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632810299?lang=en_us&edition=fundamental","pubTime":"2026-05-04 09:20","pubTimestamp":1777857641,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems To Raise A$60 Mln At A$1.85 Per ShareMay 4 (Reuters) - Imricor Medical Systems Inc IMR.AX:TO RAISE A$60.0 MILLION AT AN OFFER PRICE OF A$1.85 PER SHAREFurther company coverage: IMR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nFWN41E0LR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","BK7503","BK7508","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632989854","title":"Imricor Medical Systems - to Raise a$60.0 Mln at an Offer Price of a$1.85 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2632989854","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632989854?lang=en_us&edition=fundamental","pubTime":"2026-05-04 07:13","pubTimestamp":1777850001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260503:nFWN41E0LR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","IMR.AU","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631575958","title":"BRIEF-Imricor Medical Systems Seeks Trading Halt Pending Announcement On Proposed Capital Raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2631575958","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631575958?lang=en_us&edition=fundamental","pubTime":"2026-04-30 08:01","pubTimestamp":1777507296,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Seeks Trading Halt Pending Announcement On Proposed Capital RaisingApril 30 (Reuters) - Imricor Medical Systems Inc IMR.AX:IMRICOR MEDICAL SYSTEMS INC - TRADING HALT REQU","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41C1UE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7503","BK7508","IMR.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631759835","title":"Imricor Medical Systems Inc - Trading Halt Requested Pending Announcement on Proposed Capital Raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2631759835","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631759835?lang=en_us&edition=fundamental","pubTime":"2026-04-30 08:00","pubTimestamp":1777507210,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41C1UE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7503","BK7007","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630332881","title":"Imricor Medical Systems Expects First Sales for Mapping System in Q2","url":"https://stock-news.laohu8.com/highlight/detail?id=2630332881","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630332881?lang=en_us&edition=fundamental","pubTime":"2026-04-28 10:44","pubTimestamp":1777344279,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said the first sales in the US for its NorthStar 3D mapping and guidance system are expected in the second quarter after it received clearance from the US Food and Drug Administration , according to a Tuesday Australian bourse filing.The firm believes the US opportunity is compelling in the adult electrophysiology and in pediatric settings.It also supported the development of future commercial sites and regional expansion opportunities in the Middle East.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7503","BK7007","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627665872","title":"ASX Penny Stocks Worth Watching In April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2627665872","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627665872?lang=en_us&edition=fundamental","pubTime":"2026-04-16 10:11","pubTimestamp":1776305479,"startTime":"0","endTime":"0","summary":"As Australian shares inch closer to the 9,000-point mark, the market is navigating a mix of optimism from international indices and local concerns stemming from a significant fire at Viva Energy's Geelong refinery. In this context, penny stocks—often associated with smaller or newer companies—remain an intriguing area for investors seeking growth opportunities. Despite being considered niche, these stocks can offer substantial value when they are supported by strong financial health and clear...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-imr/imricor-medical-systems-shares/news/asx-penny-stocks-worth-watching-in-april-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-imr/imricor-medical-systems-shares/news/asx-penny-stocks-worth-watching-in-april-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7016","BK7503","CGS.AU","XAO.AU","EDU.AU","BK7060","BK7095","PPS.AU","XKO.AU","GWA.AU","CLX.AU","OEC.AU","RPL.AU","BK7058","BK7007","LBL.AU","AEF.AU","BK7012","BK7132","OBM.AU","BK7094","BK7088","BK7508","IRI.AU","BK7115","BK7062","FHE.AU","BK7104","IMR.AU","XJO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625967919","title":"BRIEF-Imricor Medical Systems Submits Northstar For U.S. Pediatric Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2625967919","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625967919?lang=en_us&edition=fundamental","pubTime":"2026-04-08 08:11","pubTimestamp":1775607085,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Submits Northstar For U.S. Pediatric ExpansionApril 8  - Imricor Medical Systems Inc IMR.AX:IMRICOR SUBMITS NORTHSTAR FOR U.S. PEDIATRIC EXPANSIONUS FDA CLEARANCE IS EXPECTED IN CURRENT QUARTERFurther company coverage: IMR.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nFWN40Q17O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMR.AU","BK7007","BK7508","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625962988","title":"Imricor Medical Systems Submits Mapping System to US FDA for Pediatric Label Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2625962988","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625962988?lang=en_us&edition=fundamental","pubTime":"2026-04-08 07:32","pubTimestamp":1775604747,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  submitted its NorthStar 3D mapping and guidance system to the US Food and Drug Administration  for pediatric label expansion through the Special 510 program, according to a Wednesday filing with the Australian bourse.The expansion is intended to support the establishment of an installed base in pediatric centers in the US, the filing said.NorthStar had received FDA clearance for the use of the system in adult patients, as disclosed in January, per the filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK7508","BK7503","BK7007","IMR.AU","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625964564","title":"Imricor Medical Systems Inc - Imricor Submits Northstar for U.S. Pediatric Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2625964564","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625964564?lang=en_us&edition=fundamental","pubTime":"2026-04-08 06:44","pubTimestamp":1775601873,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nFWN40Q17O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","IMR.AU","BK7007","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625796450","title":"Imricor Medical Systems Inc - US FDA Clearance Is Expected in Current Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2625796450","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625796450?lang=en_us&edition=fundamental","pubTime":"2026-04-08 06:44","pubTimestamp":1775601873,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nFWN40Q17O:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","BK7503","BK7508","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614720446","title":"BRIEF-Imricor Medical Systems Net Loss For Year $25.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614720446","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614720446?lang=en_us&edition=fundamental","pubTime":"2026-02-25 09:38","pubTimestamp":1771983533,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Net Loss For Year $25.3 MillionFeb 25 (Reuters) - Imricor Medical Systems Inc IMR.AX:NET LOSS FOR YEAR $25.3 MILLIONTOTAL REVENUE FOR YEAR WAS $292,309Further company coverage: IMR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZK19F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMR.AU","BK7503","BK7508","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614724872","title":"Imricor Medical Systems Posts Narrower 2025 Loss, Lower Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2614724872","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614724872?lang=en_us&edition=fundamental","pubTime":"2026-02-25 07:49","pubTimestamp":1771976956,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  reported on Wednesday a loss of $0.08 per share in 2025, compared with $0.13 a year earlier.Analysts polled by FactSet expected a loss of $0.08.Total revenue for the 12 months ended Dec. 31, 2025, was $292,309 compared with $959,424 a year earlier.The board did not declare a final dividend for the year.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU","BK7508","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614747215","title":"Imricor Medical Systems Inc -  Net Loss for Year $25.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2614747215","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614747215?lang=en_us&edition=fundamental","pubTime":"2026-02-25 04:45","pubTimestamp":1771965925,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nFWN3ZK19F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMR.AU","BK7007","BK7508","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612941014","title":"Imricor Medical Systems Secures Third Site for Heart Procedure Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2612941014","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612941014?lang=en_us&edition=fundamental","pubTime":"2026-02-18 09:22","pubTimestamp":1771377762,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said the Na Homolce Hospital in Prague, Czech Republic, will be the third site to join its VISABL-ventricular tachycardia clinical trial, with local ethics committee approval, according to a Wednesday Australian bourse filing.The trial is evaluating real-time magnetic resonance imaging-guided ventricular ablation.The company's shares were up nearly 2% in recent Wednesday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","BK7508","IMR.AU","BK7503"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}]}}